The HCPLive Cardiology condition center page is a comprehensive resource for clinical news and insights on cardiovascular and cardiometabolic diseases. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for heart disease and cardiovascular events, as well as associated diabetes, renal failure, and more...
October 25th 2024
New research indicates semaglutide reduced albuminuria and body weight in CKD patients without diabetes, highlighting its potential renal benefits.
Elevating Care for PAH: Applying Recommended Management Approaches to Maximize Outcomes
View More
‘REEL’ Time Patient Counseling™: Navigating the Complex Journey of Diagnosing and Managing Fabry Disease
View More
Expert Illustrations & Commentaries™: Envisioning Novel Therapeutic Approaches to Managing ANCA-associated Vasculitis
View More
How Should I Manage This Patient with Atrial Fibrillation
August 4th 2015A 59-year-old male with a history of hypertension and type 2 diabetes is admitted by you foratrial fibrillation found on routine examination. He indicates that the only symptoms he has experienced is tiredness for the last few weeks and mild dyspnea on exertion. He has not had any previous episodes of AF.
High Energy Exercise May Improve Cardiovascular Health in Patients with Arthritis
July 30th 2015Although many patients with arthritis have a difficult time engaging in high-intensity exercises, that may be the very thing they need to reduce their risk for cardiovascular complications associated with the disease.
Studies Show Little to No Effect on Cardiovascular Health from Testosterone Replacement Therapy
At least 5 studies indicating that testosterone replacement therapy either has no effect on cardiovascular health -- or tends to improve it -- appeared during the 3-week period immediately after the US Food and Drug Administration's controversial decision to mandate warnings about the potential cardiovascular risks of such treatment.
Direct Oral Anticoagulants Gain Wide Acceptance, Especially for Patients with Atrial Fibrillation
New research suggests that the relative ease of using novel oral anticoagulants may be spurring more patients with atrial fibrillation to try anticoagulation and stick with it.
Face-to-Face by Videoconference: Improving Diabetes Care
July 23rd 2015Columbia University's Informatics for Diabetes Education and Telemedicine (IDEATel) project, a 4-year Centers for Medicare and Medicaid Services-sponsored demonstration project, showed that a telemedicine intervention can improve glycemic, lipid, and blood pressure control.
Dawn of a New Era? A Cardiologist Takes Stock of PCSK9 Inhibitors
Friday could be a big day for cardiologists. The FDA is due to rule July 24 on what could be the first available PCSK9 inhibitor, one of a new class of cholesterol-lowering agents meant to help patients who cannot get their LDL levels low enough with statins. New York City cardiologist David Vorchheimer, MD. talks about his hopes for the new drugs, and a few concerns
Heart failure may be one of the most common conditions a cardiologist sees on a daily basis but there are also many misconceptions about its treatment and diagnosis. Whether on the football field or running an endurance race there are also other issues doctors are working to address across the scope of the cardiology field.
Understanding the Relationship between Chronic Pain and Obesity
Both chronic pain conditions and obesity are major and increasing public health concerns, and the connections between the two have been firmly established in the medical literature. But as the prevalence of obesity worldwide continues to grow, a deeper understanding of this connection could potentially benefit both practitioners and patients.
FDA Issues Alert About the Lariat Suture Delivery Device for Left Atrial Appendage Closure
The US Food and Drug Administration has warned physicians that it may be dangerous to use a device known as the Lariat to close the left atrial appendage in patients with heart arrhythmias.
Diabetes Status Linked to Thromboembolism Risk in Patients with Atrial Fibrillation
Study shows that diabetes duration (ie, how long they've had the disease) is linked with an increased risk of thromboembolism in patients with atrial fibrillation, but not with an increased risk of anticoagulation-related bleeding.
Exercise is Good and Media Coverage of Exercise is Bad
July 13th 2015The reaction to an editorial claiming that exercise alone will not help patients lose weight is illustrative of the biases held by certain groups and underscores the need for greater education and awareness of the science of weight loss for patients and clinicians.
Diabetes Risk is Reduced by Egg Consumption
July 13th 2015A recent study out of Finland found that men who ate chicken eggs on a regular basis had a lower risk of developing type 2 diabetes mellitus. Like a number of other recent studies this article stands in contrast to what was once the conventional wisdom: that eating foods high in cholesterol would increase your risk of heart disease and its risk factors.
Post-Marketing Study Shows Rivaroxaban Safe for Use in Elderly Patients with Atrial Fibrillation
A multi-year study of rivaroxaban in patients with non-valvular atrial fibrillation demonstrated that the drug is about as safe in real-world usage as it was in phase 3 trials.